TriE Medical Incs. Product Line Improves the Standard of Laboratory Testing for Metered Dose Inhalers MDIs



TriE Medical, Inc., a privately held medical device development company, has developed a shake/fire system for the testing of metered dose inhalers, to be used as a research tool, formulation device, and to collect regulatory submission data for verification and validation purposes. TriE's8217;s SFSystem is completely programmable, which allows the user to create run recipes based on difference shake distances, dwell times, and firing positions.

Research studies have been completed to compare TriE'ss SFSsystem to hand firing. The studies showed TriE's8217;s system compares closely to hand firing; pharmaceutical companies compare their metered dose inhalers to hand firing because hand firing is the historical process used in submission for FDA approval. The SFSystem improves the standard of laboratory testing for pharmaceutical organizations developing and testing metered dose inhalers (MDI) formulations, thus improving the quality of drug delivery to the patient. As the need to meet the required MDI testing standards arises, TriE's8217;s SFSystem will be on the forefront of meeting those needs.

About TriE Medical, Inc.
TriE Medical, Inc., a private corporation located near the Research Triangle Park, is a medical device and development firm with extensive expertise in medical devices designed for FDA class I, II, and III. TriE develops medical devices along any stage in the design process, and provides documentation to meet FDA approvals 510K or PMA submissions. TriE works with start-up, mid-size, and multinational companies to provide strategic product development services that will meet your regulatory and business needs.
www.triemedical.com





TriE Medical Incs. Product Line Improves the Standard of Laboratory Testing for Metered Dose Inhalers MDIs